Bicara Therapeutics Inc Common Stock

Price & Volume

Stats

52W Range	$11.10-$28.09
Market Cap	$1B
Shares Short	4M

Financials

Revenue (12 Mos)	$0
Revenue Growth (YoY)	0%
Gross Profit (12 Mos)	$0
Diluted EPS	-$3.75

News

Yahoo Finance • 11 days ago

Bicara Therapeutics Announces First Patients Enrolled in FORTIFI-HN01, a Pivotal Phase 2/3 Clinical Trial of Ficerafusp Alfa in 1L Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma

Yahoo Finance • 27 days ago

Bicara Therapeutics Presents Phase 1/1b Dose Expansion Results with Ficerafusp Alfa in Advanced Squamous Cancer of the Anal Canal at the 2025 ASCO Gastrointestinal Cancers Symposium

About

CEO	Ms. Claire Mazumdar Clemon M.B.A., Ph.D.
Address	116 Huntington Avenue, Boston, MA, United States, 02116
Sector	Healthcare
Industry	Biotechnology
Full-Time Employees	0